The purpose of this study was to investigate the relationship between peripheral immune cell markers and cognitive function in patients with schizophrenia and healthy controls.
Methods
Thirty-five patients diagnosed with schizophrenia with a stable course and a control group of 35 individuals matched by sex, education, and age were included in this cross-sectional study. The Wisconsin Card Sorting Test (WCST), the Rey Auditory Verbal Learning Test (RAVLT), and the Stroop Test were used for neuropsychological evaluation. Blood neutrophil and lymphocyte percentages, neutrophil-lymphocyte ratio (NLR), and systemic immune-inflammation index (SII) values were calculated.
Results
The female patients exhibited significantly higher NLR and neutrophil percentages than the female controls. They also demonstrated higher NLR, neutrophil percentage, and SII when compared to male patients. The increased neutrophil percentages and NLR and decreased lymphocyte percentages in the female patients were significantly correlated with worsening Stroop interference and RAVLT 1 scores. Additionally, a longer duration of illness was significantly correlated with elevated NLR, SII, and neutrophil percentage, and decreased lymphocyte percentage. A higher number of previous hospitalizations was correlated with elevated SII and decreased lymphocyte percentage. Regression analysis showed a significant association between neutrophil percentage and Stroop interference scores used to evaluate attentional functions in patients with schizophrenia.
Conclusions
These results suggest that gender and course of illness may affect NLR and SII values. An elevated neutrophil percentage may be one of the factors affecting attentional dysfunction in patients with schizophrenia. Prospective studies are now needed to verify these findings.
JääskeläinenEJuolaPHirvonenN, et al.A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull. 2013;39(6):1296-1306. doi:10.1093/schbul/sbs130
2.
GreenMFHarveyPD. Cognition in schizophrenia: past, present, and future. Schizophr Res Cogn. 2014;1(1):e1-e9. doi:10.1016/j.scog.2014.02.001
3.
TripathiAKarSKShuklaR. Cognitive deficits in schizophrenia: understanding the biological correlates and remediation strategies. Clin Psychopharmacol Neurosci. 2018;16(1):7-17. doi:10.9758/cpn.2018.16.1.7
4.
NorthHFBruggemannJCropleyV, et al.Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions. Eur Arch Psychiatr Clin Neurosci. 2021;271(4):595-607. doi:10.1007/s00406-021-01237-z
5.
BoraE. Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis. Psychol Med. 2019;49(12):1971-1979. doi:10.1017/S0033291719001685
6.
MorrensMOverloopCCoppensV, et al.The relationship between immune and cognitive dysfunction in mood and psychotic disorder: a systematic review and a meta-analysis. Mol Psychiatr. 2022;27(8):3237-3246. doi:10.1038/s41380-022-01582-y
7.
PatlolaSRDonohoeGMcKernanDP. The relationship between inflammatory biomarkers and cognitive dysfunction in patients with schizophrenia: a systematic review and meta-analysis. Prog Neuro-Psychopharmacol Biol Psychiatry. 2023;121:110668. doi:10.1016/j.pnpbp.2022.110668
8.
Trtica MajnarićLGuljašSBosnićZŠerićVWittlingerT. Neutrophil-to-Lymphocyte ratio as a cardiovascular risk marker may Be less efficient in women than in men. Biomolecules. 2021;11(4):528. doi:10.3390/biom11040528
GünayESarınç UlaşlıSAkarO, et al.Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study. Inflammation. 2014;37(2):374-380. doi:10.1007/s10753-013-9749-1
11.
LinLYangFWangY, et al.Prognostic nomogram incorporating neutrophil-to-lymphocyte ratio for early mortality in decompensated liver cirrhosis. Int Immunopharm. 2018;56:58-64. doi:10.1016/j.intimp.2018.01.007
12.
TurkmenKGuneyIYerlikayaFHTonbulHZ. The relationship between neutrophil-to-lymphocyte ratio and inflammation in end-stage renal disease patients. Ren Fail. 2012;34(2):155-159. doi:10.3109/0886022X.2011.641514
13.
MazzaMGLucchiSTringaliAGMRossettiABottiERClericiM. Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in mood disorders: a meta-analysis. Prog Neuro-Psychopharmacol Biol Psychiatry. 2018;84(PtA):229-236. doi:10.1016/j.pnpbp.2018.03.012
14.
GengYShaoYZhuD, et al.Systemic immune-inflammation index predicts prognosis of patients with esophageal squamous cell carcinoma: a propensity score-matched analysis. Sci Rep. 2016;6:39482. doi:10.1038/srep39482.
15.
KarahanSZGaziogluSDilaverIBozC. The role of thrombo-inflammatory biomarkers in the prognosis of cerebral venous sinus thrombosis. Curr Neurovascular Res. 2021;18(2):237-243. doi:10.2174/1567202618666210607151518
16.
NamKWKwonHMJeongHYParkJHKwonH. Systemic immune-inflammation index is associated with white matter hyperintensity volume. Sci Rep. 2022;12(1):7379. doi:10.1038/s41598-022-11575-0
17.
KuyumcuMEYesilYOztürkZA, et al.The evaluation of neutrophil-lymphocyte ratio in Alzheimer’s disease. Dement Geriatr Cogn Disord. 2012;34(2):69-74. doi:10.1159/000341583
18.
DongXNaoJShiJZhengD. Predictive value of routine peripheral blood biomarkers in alzheimer’s disease. Front Aging Neurosci. 2019;11:332. doi:10.3389/fnagi.2019.00332
19.
XiaoYTengZXuJ, et al.Systemic immune-inflammation index is associated with cerebral small vessel disease burden and cognitive impairment. Neuropsychiatric Dis Treat. 2023;19:403-413. doi:10.2147/NDT.S401098
20.
ÖzdinSBökeÖ. Neutrophil/lymphocyte, platelet/lymphocyte and monocyte/lymphocyte ratios in different stages of schizophrenia. Psychiatr Res. 2019;271:131-135. doi:10.1016/j.psychres.2018.11.043
21.
ZhouXWangXLiR, et al.Neutrophil-to-Lymphocyte ratio is independently associated with severe psychopathology in schizophrenia and is changed by antipsychotic administration: a large-scale cross-sectional retrospective study. Front Psychiatr. 2020;11:581061. doi:10.3389/fpsyt.2020.581061
22.
InaltekinAYağciİ. Evaluation of simple markers of inflammation and systemic immune inflammation index in schizophrenia, bipolar disorder patients and healthy controls. Türk Psikiyatri Derg. 2023;34(1):11-15. doi:10.5080/u26248
23.
FirstMBWilliamsJBWKargRSSpitzerRL. Structured Clinical Interview for DSM-5 Disorders—Clinician Version (SCID-5-CV). Arlington, VA: American Psychiatric Association Publishing; 2016.
24.
ElbirMAlp TopbaşÖBayadS, et al.Adaptation and reliability of the structured clinical Interview for DSM-5-disorders-clinician version (SCID-5/CV) to the Turkish language. Türk Psikiyatri Derg. 2019;30(1):51-56. doi:10.5080/u23431
25.
AndreasenNC. Methods for assessing positive and negative symptoms. Mod Probl Pharmacopsychiatr. 1990;24:73-88. doi:10.1159/000418013
26.
ErkocSArkonacOAtaklıCOzmenE. The validity and reliability of the scale for the assessment of positive symptoms. Dusunen Adam. 1991;4:20-24.
27.
ErkocSArkonacOAtaklıCOzmenE. The validity and reliability of the scale for the assessment of negative symptoms. Dusunen Adam. 1991;4:16-19.
28.
BergEA. A simple objective technique for measuring flexibility in thinking. J Gen Psychol. 1948;39:15-22. doi:10.1080/00221309.1948.9918159
29.
HeatonRKCheluneGJTalleyJLKayGGCurtissG. Wisconsin Card Sorting Test Manual: Revised and Expanded. Odessa, FL: Psychological Assessment Resources; 1993.
30.
KarakasSEskiRBasarE. A neuropsychological test battery standardized to the Turkish culture: BILNOT battery. In: Handbook of the 32nd National Congress of Neurology. İstanbul: Ufuk Matbaası Publishing; 1996.
31.
ReyA. L’examen Clinique en Psychologie. Paris: Presse Universitaire de France; 1958.
32.
AcıkgözDG. Empirical and Statistical Evaluation of Factor Structure of Neuropsychological Tests of Memory and Attention Functions. Master’s Thesis. Ankara: Hacettepe University Institute of Social Sciences; 1995.
33.
StroopJR. Studies of interference in serial verbal reactions. J Exp Psychol. 1935;18(6):643–662. doi: 10.1037/h0054651
34.
SpreenOStraussE. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. 2nd edNew York, NY: Oxford University Press; 1998.
35.
KarakasSErdoğanESoysalS. Stroop test TBAG form: standardisation for Turkish culture, reliability and validity. Klinik Psikiyatri Dergisi. 1999;2(2):75-88.
36.
AdamowiczDHShillingPDPalmerBW, et al.Associations between inflammatory marker profiles and neurocognitive functioning in people with schizophrenia and non-psychiatric comparison subjects. J Psychiatr Res. 2022;149:106-113. doi:10.1016/j.jpsychires.2022.02.029
37.
JosephJDeppCMartinAS, et al.Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups. Schizophr Res. 2015;168(1-2):456-460. doi:10.1016/j.schres.2015.08.019
38.
LeeEEHongSMartinASEylerLTJesteDV. Inflammation in schizophrenia: cytokine levels and their relationships to demographic and clinical variables. Am J Geriatr Psychiatr. 2017;25(1):50-61. doi:10.1016/j.jagp.2016.09.009
39.
Manda-HandzlikADemkowU. The brain entangled: the contribution of neutrophil extracellular traps to the diseases of the central nervous system. Cells. 2019;8(12):1477. doi: 10.3390/cells8121477
40.
PiersonERWagnerCAGovermanJM. The contribution of neutrophils to CNS autoimmunity. Clin Immunol. 2018;189:23-28. doi:10.1016/j.clim.2016.06.017
41.
Corsi-ZuelliFSchneiderAHSantos-SilvaT, et al.Increased blood neutrophil extracellular traps (NETs) associated with early life stress: translational findings in recent-onset schizophrenia and rodent model. Transl Psychiatry. 2022;12(1):526. doi:10.1038/s41398-022-02291-4
42.
SirotaPGavrieliRWolachB. Overproduction of neutrophil radical oxygen species correlates with negative symptoms in schizophrenic patients: parallel studies on neutrophil chemotaxis, superoxide production and bactericidal activity. Psychiatr Res. 2003;121(2):123-132. doi:10.1016/s0165-1781(03)00222-1
43.
NúñezCStephan-OttoCUsallJPEPs Group, et al.Neutrophil count is associated with reduced gray matter and enlarged ventricles in first-episode psychosis. Schizophr Bull. 2019;45(4):846-858. doi:10.1093/schbul/sby113
44.
SoehnleinOSteffensSHidalgoAWeberC. Neutrophils as protagonists and targets in chronic inflammation. Nat Rev Immunol. 2017;17(4):248-261. doi:10.1038/nri.2017.10
45.
TollABlanco-HinojoLBergeD, et al.Higher lymphocyte count associated with larger hippocampal volume and fewer depressive symptoms in drug-naive first-episode psychosis. Eur Neuropsychopharmacol. 2023;69:47-55. doi:10.1016/j.euroneuro.2023.01.002
46.
MillerBJGassamaBSebastianDBuckleyPMellorA. Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatr. 2013;73(10):993-999. doi:10.1016/j.biopsych.2012.09.007
47.
ZhuXLiRZhuY, et al.Changes in inflammatory biomarkers in patients with schizophrenia: a 3-year retrospective study. Neuropsychiatric Dis Treat. 2023;19:1597-1604. doi:10.2147/NDT.S411028
48.
UstundagYHuysalKGecgelSKUnalD. Relationship between C-reactive protein, systemic immune-inflammation index, and routine hemogram-related inflammatory markers in low-grade inflammation. Int J Med Biochem. 2018;1(1):24-28. doi:10.14744/ijmb.2017.08108
49.
YangYLWuCHHsuPF, et al.Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest. 2020;50(5):e13230. doi:10.1111/eci.13230
50.
XiaYXiaCWuLLiZLiHZhangJ. Systemic immune inflammation index (SII), system inflammation response index (SIRI) and risk of all-cause mortality and cardiovascular mortality: a 20-year follow-up cohort study of 42,875 US adults. J Clin Med. 2023;12(3):1128. doi:10.3390/jcm12031128
